Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis

Metabolic Engineering

Volumn 43, Issue , 2017, Pages 113-124

  Dong, Wentao ^a   Keibler, Mark A ^a   Stephanopoulos, Gregory ^a  

^a Massachusetts Institute of Technology   (United States)

Author keywords

Cancer metabolism; Isotopic labeling analysis

Indexed keywords

AMINO ACIDS; CELLS; DISEASES; ISOTOPES; PHYSIOLOGY;

ACETATE METABOLISM; CANCER CELLS; CANCER RESEARCH; CANCER THERAPY; ISOCITRATE DEHYDROGENASE; ISOTOPIC LABELING; ISOTOPIC TRACER; METABOLIC PATHWAYS;

METABOLISM;

ACETIC ACID; ACETYL COENZYME A; GLUTAMINE; GLYCINE; ISOCITRATE DEHYDROGENASE; SERINE; TRACER; AMINO ACID; TUMOR PROTEIN;

AMINO ACID METABOLISM; CANCER CELL; CELL METABOLISM; DEAMINATION; ENZYME ACTIVITY; GENE MUTATION; GLYCOLYSIS; HUMAN; ISOTOPE LABELING; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE; PRIORITY JOURNAL; REVIEW; TRANSAMINATION; ANIMAL; GENETICS; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY; PROCEDURES;

AMINO ACIDS; ANIMALS; GLYCOLYSIS; HUMANS; ISOCITRATE DEHYDROGENASE; ISOTOPE LABELING; MUTATION; NEOPLASM PROTEINS; NEOPLASMS;

EID: 85013664984     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2017.02.002     Document Type: Review

References (91)

1. Ahn, W.S., Zhang, Z., Cantor, J.R., Iliopoulos, O., Stephanopoulos, G., (2017). Glyceraldehyde 3-phosphate dehydrogenase modulates non-oxidative pentose phosphate pathway to provide anabolic precursors in hypoxic tumor cells (in preparation).
2. Amelio, I., Cutruzzolá, F., Antonov, A., Agostini, M., Melino, G., Serine and glycine metabolism in cancer. Trends Biochem. Sci. 39:4 (2014), 191–198, 10.1016/j.tibs.2014.02.004.
3. Barbosa, M.J., Rocha, J.M.S., Tramper, J., Wijffels, R.H., Acetate as a carbon source for hydrogen production by photosynthetic bacteria. J. Biotechnol. 85:1 (2001), 25–33, 10.1016/S0168-1656(00)00368-0.
4. Basan, M., Hui, S., Okano, H., Zhang, Z., Shen, Y., Williamson, J.R., Hwa, T., Overflow metabolism in Escherichia coli results from efficient proteome allocation. Nature 528:7580 (2015), 99–104, 10.1038/nature15765.
5. Birsoy, K., Wang, T., Chen, W.W., Freinkman, E., Abu-Remaileh, M., Sabatini, D.M., An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162:3 (2015), 540–551, 10.1016/j.cell.2015.07.016.
6. Bonnet, S., Archer, S.L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C.T., Lopaschuk, G.D., Puttagunta, L., Bonnet, S., Harry, G., Hashimoto, K., Porter, C.J., Andrade, M.A., Thebaud, B., Michelakis, E.D., A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11:1 (2007), 37–51, 10.1016/j.ccr.2006.10.020.
7. Bos, J.L., ras oncogenes in human cancer: a review. Cancer Res. 49:17 (1989), 4682–4689.
8. Bott, A.J., Peng, I.C., Fan, Y., Faubert, B., Zhao, L., Li, J., Neidler, S., Sun, Y., Jaber, N., Krokowski, D., Lu, W., Pan, J.A., Powers, S., Rabinowitz, J., Hatzoglou, M., Murphy, D.J., Jones, R., Wu, S., Girnun, G., Zong, W.X., Oncogenic Myc induces expression of glutamine synthetase through promoter demethylation. Cell Metab. 22:6 (2015), 1068–1077, 10.1016/j.cmet.2015.09.025.
9. Chen, W.W., Freinkman, E., Wang, T., Birsoy, K., Sabatini, D.M., Absolute quantification of matrix metabolites reveals the dynamics of mitochondrial metabolism. Cell 166:5 (2016), 1324–1337, 10.1016/j.cell.2016.07.040.
10. Christofk, H.R., Vander Heiden, M.G., Harris, M.H., Ramanathan, A., Gerszten, R.E., Wei, R., Fleming, M.D., Schreiber, S.L., Cantley, L.C., The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:7184 (2008), 230–233, 10.1038/nature06734.
11. Cohen, A.L., Holmen, S.L., Colman, H., IDH1 and IDH2 mutations in gliomas. Curr. Neurol. Neurosci. Rep., 13(5), 2013, 345, 10.1007/s11910-013-0345-4.
12. Comerford, S.A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A.K., Walters, H., Tantawy, M.N., Fu, A., Manning, H.C., Horton, J.D., Hammer, R.E., Mcknight, S.L., Tu, B.P., Acetate dependence of tumors. Cell 159:7 (2014), 1591–1602, 10.1016/j.cell.2014.11.020.
13. Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M., Fantin, V.R., Jang, H.G., Jin, S., Keenan, M.C., Marks, K.M., Prins, R.M., Ward, P.S., Yen, K.E., Liau, L.M., Rabinowitz, J.D., Cantley, L.C., Thompson, C.B., Vander Heiden, M.G., Su, S.M., Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:7274 (2009), 739–744, 10.1038/nature08617.
14. Dang, C.V., Kim, J., Gao, P., Yustein, J., The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 8:1 (2008), 51–56, 10.1038/nrc2274.
15. Davidson, S.M., Papagiannakopoulos, T., Olenchock, B.A., Heyman, J.E., Keibler, M.A., Luengo, A., Bauer, M.R., Jha, A.K., O'Brien, J.P., Pierce, K.A., Gui, D.Y., Sullivan, L.B., Wasylenko, T.M., Subbaraj, L., Chin, C.R., Stephanopolous, G., Mott, B.T., Jacks, T., Clish, C.B., Vander Heiden, M.G., Environment impacts the metabolic dependencies of ras-driven non-small cell lung cancer. Cell Metab. 23:3 (2016), 517–528, 10.1016/j.cmet.2016.01.007.
16. de Koning, T.J., Snell, K., Duran, M., Berger, R., Poll-The, B.-T., Surtees, R., L-serine in disease and development. Biochem. J. 371:3 (2003), 653–661, 10.1042/BJ20021785.
17. Deberardinis, R.J., Serine metabolism: some tumors take the road less traveled. Cell Metab. 14:3 (2011), 285–286, 10.1016/j.cmet.2011.08.004.
18. DeNicola, G.M., Chen, P.-H., Mullarky, E., Sudderth, J.A., Hu, Z., Wu, D., Tang, H., Xie, Y., Asara, J.M., Huffman, K.E., Wistuba, I.I., Minna, J.D., DeBerardinis, R.J., Cantley, L.C., NRF2 regulates serine biosynthesis in non–small cell lung cancer. Nat. Genet. 47:12 (2015), 1475–1481, 10.1038/ng.3421.
19. Dhillon, A.S., Hagan, S., Rath, O., Kolch, W., MAP kinase signalling pathways in cancer. Oncogene 26:22 (2007), 3279–3290, 10.1038/sj.onc.1210421.
20. Diaz-Moralli, S., Aguilar, E., Marin, S., Coy, J.F., Dewerchin, M., Antoniewicz, M.R., Meca-Cortés, O., Notebaert, L., Ghesquière, B., Eelen, G., Thomson, T.M., Carmeliet, P., Cascante, M., A key role for transketolase-like 1 in tumor metabolic reprogramming. Oncotarget, 7(32), 2016, 10.18632/oncotarget.10429.
21. Ducker, G.S., Rabinowitz, J.D., One-carbon metabolism in health and disease. Cell Metab. 25:1 (2017), 1–16, 10.1016/j.cmet.2016.08.009.
22. Fan, J., Kamphorst, J.J., Rabinowitz, J.D., Shlomi, T., Fatty acid labeling from glutamine in hypoxia can be explained by isotope exchange without net reductive isocitrate dehydrogenase (IDH) flux. J. Biol. Chem. 288:43 (2013), 31363–31369, 10.1074/jbc.M113.502740.
23. Fang, J., Quinones, Q.J., Holman, T.L., Morowitz, M.J., Wang, Q., Zhao, H., Sivo, F., Maris, J.M., Wahl, M.L., The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Mol. Pharmacol. 70:6 (2006), 2108–2115, 10.1124/mol.106.026245.
24. Farber, S., Diamond, L.K., Mercer, R.D., Sylvester, R.F.J., Wolff, J.A., Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). New Engl. J. Med. 238:23 (1948), 787–793, 10.1056/NEJM194806032382301.
25. Fendt, S.-M., Bell, E.L., Keibler, M.A., Olenchock, B.A., Mayers, J.R., Wasylenko, T.M., Vokes, N.I., Guarente, L., Vander Heiden, M.G., Stephanopoulos, G., Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells. Nat. Commun., 4(2236), 2013, 10.1038/ncomms3236.
26. Fothergill-Gilmore, L.A., Watson, H.C., Phosphoglycerate mutases. Biochem. Soc. Trans. 18:2 (1990), 190–193, 10.1042/bst0180190.
27. Gaglio, D., Metallo, C.M., Gameiro, P.A., Hiller, K., Danna, L.S., Balestrieri, C., Alberghina, L., Stephanopoulos, G., Chiaradonna, F., Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol. Syst. Biol., 7, 2011, 523, 10.1038/msb.2011.56.
28. Gameiro, P.A., Yang, J., Metelo, A.M., Pérez-Carro, R., Baker, R., Wang, Z., Arreola, A., Rathmell, W.K., Olumi, A., López-Larrubia, P., Stephanopoulos, G., Iliopoulos, O., In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. Cell Metab. 17:3 (2013), 372–385, 10.1016/j.cmet.2013.02.002.
29. Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K.I., De Marzo, A.M., Van Eyk, J.E., Mendell, J.T., Dang, C.V., C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458:7239 (2009), 762–765, 10.1038/nature07823.
30. Garber, K., Cancer anabolic metabolism inhibitors move into clinic. Nat. Biotechnol. 34:8 (2016), 794–795, 10.1038/nbt0816-794.
31. Garrow, T.A., Brenner, A.A., Whitehead, V.M., Chen, X.N., Duncan, R.G., Korenberg, J.R., Shane, B., Cloning of human cDNAs encoding mitochondrial and cytosolic serine hydroxymethyltransferases and chromosomal localization. J. Biol. Chem. 268:16 (1993), 11910–11916.
32. Grassian, A.R., Parker, S.J., Davidson, S.M., Divakaruni, A.S., Green, C.R., Zhang, X., Slocum, K.L., Pu, M., Lin, F., Vickers, C., Joud-Caldwell, C., Chung, F., Yin, H., Handly, E.D., Straub, C., Growney, J.D., Vander Heiden, M.G., Murphy, A.N., Pagliarini, R., Metallo, C.M., IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Res. 74:12 (2014), 3317–3331, 10.1158/0008-5472.CAN-14-0772-T.
33. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell, 144(5), 2011, 10.1016/j.cell.2011.02.013.
34. Heath, E.C., Hurwitz, J., Horecker, B.L., Ginsburg, A., Pentose fermentation by Lactobacillus plantarum. I. The cleavage of xylulose 5-phosphate by phosphoketolase. J. Biol. Chem. 231:2 (1958), 1009–1029.
35. Hensley, C.T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., Wodzak, M., Klimko, C., McMillan, E., Butt, Y., Ni, M., Oliver, D., Torrealba, J., Malloy, C.R., Kernstine, K., Lenkinski, R.E., DeBerardinis, R.J., Metabolic heterogeneity in human lung tumors. Cell 164:4 (2016), 681–694, 10.1016/j.cell.2015.12.034.
36. Hensley, C.T., Wasti, A.T., Deberardinis, R.J., Glutamine and cancer: cell biology, physiology, and clinical opportunities. J. Clin. Investig. 123:9 (2013), 3678–3684, 10.1172/JCI69600.3678.
37. Hiller, K., Metallo, C.M., Profiling metabolic networks to study cancer metabolism. Curr. Opin. Biotechnol. 24:1 (2013), 60–68, 10.1016/j.copbio.2012.11.001.
38. Hitosugi, T., Kang, S., Vander Heiden, M.G., Chung, T., Elf, S., Lythgoe, K., Dong, S., Lonial, S., Wang, X., Chen, G.Z., Xie, J., Gu, T.L., Polakiewicz, R.D., Roesel, J.L., Boggon, T.J., Khuri, F.R., Gilliland, D.G., Cantley, L.C., Kaufman, J., Chen, J., Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci. Signal. 2:97 (2010), 1–16, 10.1126/scisignal.2000431.Tyrosine.
39. Hosios, A.M., Hecht, V.C., Danai, L.V., Johnson, M.O., Rathmell, J.C., Steinhauser, M.L., Manalis, S.R., Vander Heiden, M.G., Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev. Cell 36:5 (2016), 540–549, 10.1016/j.devcel.2016.02.012.
40. Hosios, A.M., Vander Heiden, M.G., Acetate metabolism in cancer cells. Cancer Metab., 2(1), 2014, 27, 10.1186/s40170-014-0027-y.
41. Hsu, P.P., Sabatini, D.M., Cancer cell metabolism: Warburg and beyond. Cell 134:5 (2008), 703–707, 10.1016/j.cell.2008.08.021.
42. Kamphorst, J.J., Chung, M.K., Fan, J., Rabinowitz, J.D., Quantitative analysis of acetyl-CoA production in hypoxic cancer cells reveals substantial contribution from acetate. Cancer & Metabolism, 2, 2014, 23, 10.1186/2049-3002-2-23.
43. Kamphorst, J.J., Cross, J.R., Fan, J., de Stanchina, E., Mathew, R., White, E.P., Thompson, C.B., Rabinowitz, J.D., Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc. Natl. Acad. Sci. USA 110:22 (2013), 8882–8887, 10.1073/pnas.1307237110.
44. Kölker, S., Pawlak, V., Ahlemeyer, B., Okun, J.G., Hörster, F., Mayatepek, E., Krieglstein, J., Hoffmann, G.F., Köhr, G., NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria. Eur. J. Neurosci. 16:1 (2002), 21–28, 10.1046/j.1460-9568.2002.02055.x.
45. Korri, U., Nuutinen, H., Salaspuro, M., Increased blood acetate: a new laboratory marker of alcoholism and heavy drinking. Alcohol. Clin. Exp. Res. 9:5 (1985), 468–471.
46. Latini, A., Scussiato, K., Rosa, R.B., Llesuy, S., Belló-Klein, A., Dutra-Filho, C.S., Wajner, M., D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats. Eur. J. Neurosci. 17:10 (2003), 2017–2022, 10.1046/j.1460-9568.2003.02639.x.
47. Lewis, C.A., Parker, S.J., Fiske, B.P., McCloskey, D., Gui, D.Y., Green, C.R., Vokes, N.I., Feist, A.M., Vander Heiden, M.G., Metallo, C.M., Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell 55:2 (2014), 253–263, 10.1016/j.molcel.2014.05.008.
48. Liberti, M.V., Locasale, J.W., The Warburg effect: how does it benefit cancer cells?. Trends Biochem. Sci. 41:3 (2016), 211–218, 10.1016/j.tibs.2015.12.001.
49. Liu, N., Qiao, K., Stephanopoulos, G., 13C Metabolic Flux Analysis of acetate conversion to lipids by Yarrowia lipolytica. Metab. Eng., 38, 2016, 10.1016/j.ymben.2016.06.006.
50. Liu, W., Le, A., Hancock, C., Lane, A.N., Dang, C.V., Fan, T.W.-M., Phang, J.M., Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc. Natl. Acad. Sci. USA 109:23 (2012), 8983–8988, 10.1073/pnas.1203244109.
51. Locasale, J.W., Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13:8 (2013), 572–583, 10.1038/nrc3557.
52. Locasale, J.W., Grassian, A.R., Melman, T., Lyssiotis, C.A., Mattaini, K.R., Bass, A.J., Heffron, G., Metallo, C.M., Muranen, T., Sharfi, H., Sasaki, A.T., Anastasiou, D., Mullarky, E., Vokes, N.I., Sasaki, M., Beroukhim, R., Stephanopoulos, G., Ligon, A.H., Meyerson, M., Richardson, A.L., Chin, L., Wagner, G., Asara, J.M., Brugge, J.S., Cantley, L.C., Vander Heiden, M.G., Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43:9 (2011), 869–874, 10.1038/ng.890.
53. Lu, C., Ward, P., Kapoor, G., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C.R., Khanin, R., Figueroa, M.E., Melnick, A., Wellen, K.E., O'Rourke, D.M., Berger, S.L., Chan, T.A., Levine, R.L., Mellinghoff, I.K., Thompson, C.B., IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483:7390 (2012), 474–478, 10.1038/nature10860.IDH.
54. Lyssiotis, C.A., Cantley, L.C., Acetate fuels the cancer engine. Cell 159:7 (2014), 1492–1494, 10.1016/j.cell.2014.12.009.
55. Maher, E.A., Marin-Valencia, I., Bachoo, R.M., Mashimo, T., Raisanen, J., Hatanpaa, K.J., Jindal, A., Jeffrey, F.M., Choi, C., Madden, C., Mathews, D., Pascual, J.M., Mickey, B.E., Malloy, C.R., DeBerardinis, R.J., Metabolism of [U-13C]glucose in human brain tumors in vivo. NMR Biomed. 25:11 (2012), 1234–1244, 10.1002/nbm.2794.
56. Mardis, E.E.R.E., Ding, L., Dooling, D.J., Larson, D.E., McLellan, M.D., Chen, K., Koboldt, D.C., Fulton, R.S., Delehaunty, K.D., McGrath, S.D., Fulton, L.A., Locke, D.P., Magrini, V.J., Abbott, R.M., Vickery, T.L., Reed, J.S., Robinson, J.S., Wylie, T., Smith, S.M., Carmichael, L., Eldred, J.M., Harris, C.C., Walker, J., Peck, J.B., Du, F., Dukes, A.F., Sanderson, G.E., Brummett, A.M., Clark, E., McMichael, J.F., Meyer, R.J., Schindler, J.K., Pohl, C.S., Wallis, J.W., Shi, X., Lin, L., Schmidt, H., Tang, Y., Haipek, C., Wiechert, M.E., Ivy, J.V., Kalicki, J., Elliott, G., Ries, R.E., Payton, J.E., Westervelt, P., Tomasson, M.H., Watson, M.A., Baty, J., Heath, S., Shannon, W.D., Nagarajan, R., Link, D.C., Walter, M.J., Graubert, T.A., DiPersio, J.F., Wilson, R.K., Ley, T.J., Recurring mutations found by sequencing an acute myeloid leukemia genome. New Engl. J. Med. 361:11 (2009), 1058–1066, 10.1056/NEJMoa0903840.
57. Mashimo, T., Pichumani, K., Vemireddy, V., Hatanpaa, K.J., Singh, D.K., Sirasanagandla, S., Nannepaga, S., Piccirillo, S.G., Kovacs, Z., Foong, C., Huang, Z., Barnett, S., Mickey, B.E., DeBerardinis, R.J., Tu, B.P., Maher, E.A., Bachoo, R.M., Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159:7 (2014), 1603–1614, 10.1016/j.cell.2014.11.025.
58. Metallo, C.M., Gameiro, P.A., Bell, E.L., Mattaini, K.R., Yang, J., Hiller, K., Jewell, C.M., Johnson, Z.R., Irvine, D.J., Guarente, L., Kelleher, J.K., Vander Heiden, M.G., Iliopoulos, O., Stephanopoulos, G., Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. TL −481. Nature 481 VN:VN-(7381) (2011), 380–384, 10.1038/nature10602.
59. Kang, M.R., Kim, M.S., Oh, J.E., Kim, Y.R., Song, S.Y., Seo, S.I., Lee, J.Y., Yoo, N.J., Lee, S.H., Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int. J. Cancer 125:2 (2009), 353–355, 10.1002/ijc.24379.
60. Mullen, A.R., Wheaton, W.W., Jin, E.S., Chen, P.-H., Sullivan, L.B., Cheng, T., Yang, Y., Linehan, W.M., Chandel, N.S., DeBerardinis, R.J., Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481:7381 (2012), 385–388, 10.1038/nature10642.
61. Nuutinen, H., Lindros, K., Hekali, P., Salaspuro, M., Elevated blood acetate as indicator of fast ethanol elimination in chronic alcoholics. Alcohol 2:4 (1985), 623–626, 10.1016/0741-8329(85)90090-4.
62. Pacold, M.E., Brimacombe, K.R., Chan, S.H., Rohde, J.M., Lewis, C.A., Swier, L.J., Possemato, R., Chen, W.W., Sullivan, L.B., Fiske, B.P., Cho, S., Freinkman, E., Birsoy, K., Abu-Remaileh, M., Shaul, Y.D., Liu, C.M., Zhou, M., Koh, M.J., Chung, H., Davidson, S.M., Luengo, A., Wang, A.Q., Xu, X., Yasgar, A., Liu, L., Rai, G., Westover, K.D., Vander Heiden, M.G., Shen, M., Gray, N.S., Boxer, M.B., Sabatini, D.M., A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat. Chem. Biol., 12(4), 2016, 10.1038/nchembio.2070.
63. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.E., Karandikar, M., Berman, K., Cobb, M.H., Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:2 (2001), 153–183, 10.1210/edrv.22.2.0428.
64. Pollari, S., Käkönen, S.M., Edgren, H., Wolf, M., Kohonen, P., Sara, H., Guise, T., Nees, M., Kallioniemi, O., Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res. Treat. 125:2 (2011), 421–430, 10.1007/s10549-010-0848-5.
65. Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W., Vogelstein, B., A model for p53-induced apoptosis. Nature 389:6648 (1997), 300–305, 10.1038/38525.
66. Possemato, R., Marks, K.M., Shaul, Y.D., Pacold, M.E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.K., Jang, H.G., Jha, A.K., Chen, W.W., Barrett, F.G., Stransky, N., Tsun, Z.Y., Cowley, G.S., Barretina, J., Kalaany, N.Y., Hsu, P.P., Ottina, K., Chan, A.M., Yuan, B., Garraway, L.A., Root, D.E., Mino-Kenudson, M., Brachtel, E.F., Driggers, E.M., Sabatini, D.M., Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476:7360 (2011), 346–350, 10.1038/nature10350.
67. Renwick, S.B., Snell, K., Baumann, U., The crystal structure of human cytosolic serine hydroxymethyltransferase: a target for cancer chemotherapy. Structure 6:9 (1998), 1105–1116, 10.1016/S0969-2126(98)00112-9.
68. Riedl, S.J., Salvesen, G.S., The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 8:5 (2007), 405–413, 10.1038/nrm2153.
69. Ruiz-Ramírez, A., Ortiz-Balderas, E., Cardozo-Saldaña, G., Diaz-Diaz, E., El-Hafidi, M., Glycine restores glutathione and protects against oxidative stress in vascular tissue from sucrose-fed rats. Clin. Sci. 126:1 (2014), 19–29, 10.1042/CS20130164.
70. Sauer, U., Metabolic networks in motion: 13C‐based flux analysis. Mol. Syst. Biol., 2(1), 2006, 62, 10.1038/msb4100109.
71. Schramm, M., Klybas, V., Racker, E., Phosphorolytic cleavage of fructose-6-phosphate by fructose-6-phosphate phosphoketolase from acetobacter xylinum. J. Biol. Chem. 233:6 (1958), 1283–1288.
72. Schug, Z.T., Peck, B., Jones, D.T., Zhang, Q., Grosskurth, S., Alam, I.S., Goodwin, L.M., Smethurst, E., Mason, S., Blyth, K., McGarry, L., James, D., Shanks, E., Kalna, G., Saunders, R.E., Jiang, M., Howell, M., Lassailly, F., Thin, M.Z., Spencer-Dene, B., Stamp, G., van den Broek, N.J., Mackay, G., Bulusu, V., Kamphorst, J.J., Tardito, S., Strachan, D., Harris, A.L., Aboagye, E.O., Critchlow, S.E., Wakelam, M.J., Schulze, A., Gottlieb, E., Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27:1 (2015), 57–71, 10.1016/j.ccell.2014.12.002.
73. Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., Nevins, J.R., Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14:19 (2000), 2501–2514, 10.1101/gad.836800.
74. Smith, M.R., Mah, R.A., Acetate as sole carbon and energy source for growth of Methanosarcina strain 227. Appl. Environ. Microbiol. 39:5 (1980), 993–999.
75. Smith, R.J., Glutamine metabolism and its physiologic importance. J. Parenter. Enterral Nutr. 14:4 (1990), 40–44 Retrieved from: 〈 http://pen.sagepub.com/content/14/4_suppl/40S.short〉.
76. Son, J., Lyssiotis, C.A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R.M., Ferrone, C.R., Mullarky, E., Shyh-Chang, N., Kang, Y., Fleming, J.B., Bardeesy, N., Asara, J.M., Haigis, M.C., DePinho, R.A., Cantley, L.C., Kimmelman, A.C., Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496:7443 (2013), 101–105, 10.1038/nature12040.
77. Sousa, C.M., Biancur, D.E., Wang, X., Halbrook, C.J., Sherman, M.H., Zhang, L., Kremer, D., Hwang, R.F., Witkiewicz, A.K., Ying, H., Asara, J.M., Evans, R.M., Cantley, L.C., Lyssiotis, C.A., Kimmelman, A.C., Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nat. Publ. Group 536:7617 (2016), 479–483, 10.1038/nature19084.
78. Sullivan, L.B., Gui, D.Y., Hosios, A.M., Bush, L.N., Freinkman, E., Vander Heiden, M.G., Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162:3 (2015), 552–563, 10.1016/j.cell.2015.07.017.
79. Vander Heiden, M.G., Cantley, L.C., Thompson, C.B., Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:5 (2009), 1029–1034, 10.1126/science.1160809.
80. Vander Heiden, M.G., Locasale, J.W., Swanson, K.D., Sharfi, H., Heffron, G.J., Amador-Noguez, D., Christofk, H.R., Wagner, G., Rabinowitz, J.D., Asara, J.M., Cantley, L.C., Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329:5998 (2010), 1492–1499, 10.1126/science.1188015.
81. Vander Heiden, M.G., Lunt, S.Y., Dayton, T.L., Fiske, B.P., Israelsen, W.J., Mattaini, K.R., Vokes, N.I., Stephanopoulos, G., Cantley, L.C., Metallo, C.M., Locasale, J.W., Metabolic pathway alterations that support cell proliferation. Cold Spring Harb. Symp. Quant. Biol. 76 (2011), 325–334, 10.1101/sqb.2012.76.010900.
82. Warburg, O., On the origin of cancer cells. Science 123:3191 (1956), 309–314, 10.1126/science.123.3191.309.
83. Ward, P.S., Patel, J., Wise, D.R., Abdel-Wahab, O., Bennett, B.D., Coller, H.A., Cross, J.R., Fantin, V.R., Hedvat, C.V., Perl, A.E., Rabinowitz, J.D., Carroll, M., Su, S.M., Sharp, K.A., Levine, R.L., Thompson, C.B., The common feature of leukemia-associated IDH1 and IDH2 mutations is a Neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17:3 (2010), 225–234, 10.1016/j.ccr.2010.01.020.
84. Weindl, D., Wegner, A., Hiller, K., MIA: non-targeted mass isotopolome analysis. Bioinformatics 32:18 (2016), 2875–2876, 10.1093/bioinformatics/btw317.
85. Wise, D.R., Thompson, C.B., Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 35:8 (2011), 427–433, 10.1016/j.tibs.2010.05.003.Glutamine.
86. Wise, D.R., Ward, P.S., Shay, J.E., Cross, J.R., Gruber, J.J., Sachdeva, U.M., Platt, J.M., DeMatteo, R.G., Simon, M.C., Thompson, C.B., Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad. Sci. USA 108:49 (2011), 19611–19616, 10.1073/pnas.1117773108.
87. Ying, H., Kimmelman, A.C., Lyssiotis, C.A., Hua, S., Chu, G.C., Fletcher-Sananikone, E., Locasale, J.W., Son, J., Zhang, H., Coloff, J.L., Yan, H., Wang, W., Chen, S., Viale, A., Zheng, H., Paik, J.H., Lim, C., Guimaraes, A.R., Martin, E.S., Chang, J., Hezel, A.F., Perry, S.R., Hu, J., Gan, B., Xiao, Y., Asara, J.M., Weissleder, R., Wang, Y.A., Chin, L., Cantley, L.C., DePinho, R.A., Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149:3 (2012), 656–670, 10.1016/j.cell.2012.01.058.
88. Yoo, H., Antoniewicz, M.R., Stephanopoulos, G., Kelleher, J.K., Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line. J. Biol. Chem. 283:30 (2008), 20621–20627, 10.1074/jbc.M706494200.
89. Yun, J., Mullarky, E., Lu, C., Bosch, K.N., Kavalier, A., Rivera, K., Roper, J., Chio, I.I., Giannopoulou, E.G., Rago, C., Muley, A., Asara, J.M., Paik, J., Elemento, O., Chen, Z., Pappin, D.J., Dow, L.E., Papadopoulos, N., Gross, S.S., Cantley, L.C., Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350:6266 (2015), 1391–1396, 10.1126/science.aaa5004.
90. Zhang, J., Ahn, W.S., Gameiro, P.A., Keibler, M.A., Zhang, Z., Stephanopoulos, G., 13C isotope-assisted methods for quantifying glutamine metabolism in cancer cells. Methods Enzymol. 542 (2014), 369–389, 10.1016/B978-0-12-416618-9.00019-4.
91. Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., Ding, J., Lei, Q., Guan, K.L., Xiong, Y., Glioma-derived mutations in IDH1 Dominantly inhibit IDH1 catalytic activity and induce HIF-1. Science 324:5924 (2009), 261–265, 10.1126/science.1170944.